PROMOMED DM LLC has successfully placed the third issue of exchange-traded bonds worth 2.5 billion rubles

PROMOMED DM LLC has successfully placed the third issue of exchange-traded bonds. Against the background of high investor interest, the issue volume was increased from 1.5 to 2.5 billion rubles, and the coupon rate was 11.50% per annum. Both retail and institutional investors participated in the placement.

The nominal value of one bond is 1,000 rubles. The placement price is 100% of the face value. The circulation period is 1092 days. The coupon period is 182 days. The placement method is an open subscription. The placement took place on the Moscow Stock Exchange, the issue is included in the Third level of listing. The issue meets the requirements for investing pension savings and insurance reserves.

The company traditionally invests the funds received from the placement of bonds in the development and expansion of production, as well as in the development and registration of new medicines. Today, Promomed's strategy is based on the balance of creating its own innovative medicines, as well as developing generics with improved characteristics.

"Attracting market financing through the third issue of exchange–traded bonds will allow us to maintain growth rates, provide patients with new highly effective domestic drugs, and the market with pharmaceutical substances to strengthen the country's drug independence," commented Peter Bely, Chairman of the Board of Directors of PROMOMED DM LLC.

The previous placements of PROMOMED DM LLC's 001P-01 and 001P-02 series of exchange-traded bonds on the Moscow Stock Exchange took place on December 25, 2020 and July 30, 2021, when the company raised 1 billion and 1.5 billion rubles, respectively.